ReviewFrontiers in immunology2026

Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review.

Zulin Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.